Olivier De Moor

This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Summit Corporation Plc, Summit Therapeutics Plc. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier De Moor. Retrieved from https://idiyas.com/inventor/olivier-de-moor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 7)

% Patents Active = 50.0

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 20(Granted Patents)

Location History:

Oxford, GB (2013)
Oxfordshire, GB (2015)
Abingdon, GB (2012 - 2017)

Company Filing History:

4 out of 6

Summit Corporation Plc

patents

2 out of 3

Summit Therapeutics Plc

patents

Years Active: 2012-2017

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9763925 - Antibacterial compounds (2017-09-19),

2. 9314456 - Antibacterial compounds (2016-04-19),

3. 8975416 - Antibacterial compounds (2015-03-10),

4. 8518980 - Treatment of Duchenne muscular dystrophy (2013-08-27),

5. 8501713 - Drug combinations for the treatment of duchenne muscular dystrophy (2013-08-06),

6. 8138351 - Treatment of duchenne muscular dystrophy (2012-03-20),

Title: Olivier De Moor: Innovator in Antibacterial Compounds

Introduction

Olivier De Moor is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of antibacterial compounds, holding a total of 6 patents. His work focuses on developing innovative solutions for treating bacterial diseases and infections.

Latest Patents

Among his latest patents, Olivier has disclosed compounds of formula (I) that are useful in the treatment of bacterial diseases and infections. These compounds are integral to compositions designed for treating such infections. In particular, they are effective against infections caused by various bacterial pathogens.

Career Highlights

Olivier has worked with prominent companies in the pharmaceutical sector, including Summit Corporation Plc and Summit Therapeutics Plc. His experience in these organizations has allowed him to advance his research and development efforts in antibacterial treatments.

Collaborations

Olivier has collaborated with esteemed colleagues such as Graham Michael Wynne and Peter David Johnson. These partnerships have contributed to the success of his innovative projects and the advancement of antibacterial research.

Conclusion

Olivier De Moor's work in the field of antibacterial compounds showcases his dedication to improving healthcare through innovation. His patents and collaborations reflect his commitment to addressing critical medical challenges.

Profile summary based on public USPTO records.